Faes Farma is a Spanish pharmaceutical company dedicated to researching, producing, and commercialising pharmaceutical products and raw materials globally. ​

Founded in 1933, Faes Farma has over 90 years of experience in the pharmaceutical industry. The company operates internationally, with a presence in more than 130 countries. Its headquarters, production, and research facilities are located in Leioa, Spain. Faes Farma is listed on the Continuous Market of the Madrid, Valencia, Bilbao, and Barcelona stock exchanges. ​

Key Products and Services:

Pharmaceutical Products: Faes Farma’s portfolio includes prescription medicines across various therapeutic areas. Notable molecules developed by the company are bilastine, calcifediol, and mesalazine. ​

Animal Nutrition and Health: Through its FARM Faes division, the company offers products for animal nutrition and health, operating through subsidiaries such as Ingaso Farm, Tecnovit, and Capselos. ​

Research and Development: Faes Farma invests in R&D to innovate and develop new pharmaceutical products, focusing on areas like asthma and COPD. ​

With a workforce of over 1,700 professionals, Faes Farma continues to expand its global footprint, aiming to provide innovative and quality health solutions worldwide.